A deep learning pathomic signature predicts survival and recurrence in pancreatic ductal adenocarcinoma independent of CA19-9

Authors:

Abstract
No abstract available
Funding Information
  • Peking University First Hospital (2023IR23)
  • Peking University First Hospital (2024IR11)
  • National Key Research and Development Program of China (2021YFA0909900)
  • National Key Research and Development Program of China (2023YFC2413400)
  • Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research (BMU2025JI002)
  • Fundamental Research Funds for the Central Universities
  • National Health Commission of the People's Republic of China
  • National Natural Science Foundation of China (82171722)
  • National Natural Science Foundation of China (82271764)
  • National Natural Science Foundation of China (82471772)
  • Peking University (2024YXXLHGG008)
  • Natural Science Foundation of Beijing Municipality (L246015)

This publication has 61 references indexed in Scilit: